The analysis according to the expression of CD4 and CD8 coreceptors showed no statistically significant differences in the expression of LAG-3 in CD4 + T cells and CD8 + T cells between AML patients and healthy donors (Fig. 2d). This evidence concerns the gene LAG3 and acute myeloid leukemia.